66 related articles for article (PubMed ID: 27825470)
1. Monoclonal IgM-related AL amyloidosis.
Milani P; Merlini G
Best Pract Res Clin Haematol; 2016 Jun; 29(2):241-248. PubMed ID: 27825470
[TBL] [Abstract][Full Text] [Related]
2. AL amyloidosis: from molecular mechanisms to targeted therapies.
Merlini G
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):1-12. PubMed ID: 29222231
[TBL] [Abstract][Full Text] [Related]
3. Gene editing in patients with amyloidosis.
Lim GB
Nat Rev Cardiol; 2021 Sep; 18(9):611. PubMed ID: 34244678
[No Abstract] [Full Text] [Related]
4. [Clinical characteristics and prognostic analysis of monoclonal IgM-related AL amyloidosis].
Mao YY; Feng J; Meng Q; Shen KN; Cao XX; Zhou DB; Li J
Zhonghua Xue Ye Xue Za Zhi; 2017 Nov; 38(11):989-992. PubMed ID: 29224328
[No Abstract] [Full Text] [Related]
5. Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous stem cell transplantation.
Cowan AJ; Klippel ZK; Stevenson PA; Hyun TS; Tuazon S; Becker PS; Green DJ; Holmberg LA; Coffey DG; Gopal AK; Libby EN
Amyloid; 2016 Dec; 23(4):254-259. PubMed ID: 27879147
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib-dexamethasone versus high-dose melphalan for Japanese patients with systemic light-chain (AL) amyloidosis: a retrospective single-center study.
Katoh N; Ueno A; Yoshida T; Tazawa KI; Shimojima Y; Gono T; Sekijima Y; Matsuda M; Ikeda SI
Int J Hematol; 2017 Mar; 105(3):341-348. PubMed ID: 27832515
[TBL] [Abstract][Full Text] [Related]
7. Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry.
Kourelis TV; Dasari S; Theis JD; Ramirez-Alvarado M; Kurtin PJ; Gertz MA; Zeldenrust SR; Zenka RM; Dogan A; Dispenzieri A
Blood; 2017 Jan; 129(3):299-306. PubMed ID: 27856462
[TBL] [Abstract][Full Text] [Related]
8. First report of ibrutinib in IgM-related amyloidosis: few responses, poor tolerability, and short survival.
Pika T; Hegenbart U; Flodrova P; Maier B; Kimmich C; Schönland SO
Blood; 2018 Jan; 131(3):368-371. PubMed ID: 29180400
[No Abstract] [Full Text] [Related]
9. Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response.
Grogan M; Dispenzieri A; Gertz MA
Heart; 2017 Jul; 103(14):1065-1072. PubMed ID: 28456755
[TBL] [Abstract][Full Text] [Related]
10. Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic Review.
Gertz MA; Dispenzieri A
JAMA; 2020 Jul; 324(1):79-89. PubMed ID: 32633805
[TBL] [Abstract][Full Text] [Related]
11. Amyloidosis of the Lung.
Khoor A; Colby TV
Arch Pathol Lab Med; 2017 Feb; 141(2):247-254. PubMed ID: 28134587
[TBL] [Abstract][Full Text] [Related]
12. IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological features.
Sidana S; Larson DP; Greipp PT; He R; McPhail ED; Dispenzieri A; Murray DL; Dasari S; Ansell SM; Muchtar E; Gonsalves WI; Kourelis TV; Ramirez-Alvarado M; Kapoor P; Rajkumar SV; Lacy MQ; Buadi FK; Leung N; Kyle RA; Kumar SK; King RL; Gertz MA
Leukemia; 2020 May; 34(5):1373-1382. PubMed ID: 31780812
[TBL] [Abstract][Full Text] [Related]
13. Treatment of IgM-associated immunoglobulin light-chain amyloidosis with rituximab-bendamustine.
Manwani R; Sachchithanantham S; Mahmood S; Foard D; Sharpley F; Rezk T; Lane T; Quarta C; Fontana M; Lachmann HJ; Gillmore JD; Whelan C; Hawkins PN; Wechalekar AD
Blood; 2018 Aug; 132(7):761-764. PubMed ID: 29925500
[No Abstract] [Full Text] [Related]
14. Amyloid Light-Chain (AL) Amyloidosis of the Trachea Associated With an Indolent B-cell Neoplasm.
Trikannad AK; Shrestha A; Vellanki S; Cheema HI; Patel TH; Bachu R; Sharma S; Jeffus SK; Thanendrarajan S
Cureus; 2024 Jan; 16(1):e53074. PubMed ID: 38414681
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and referral of patients with AL amyloidosis in Portugal: results from a Delphi panel.
Bergantim R; Caetano A; Silva FF; Tavares I; Ferreira M; Jaime AR; Esteves GV
Porto Biomed J; 2023; 8(5):e231. PubMed ID: 37846303
[TBL] [Abstract][Full Text] [Related]
16. A Strategy for the Selection of RT-qPCR Reference Genes Based on Publicly Available Transcriptomic Datasets.
Nevone A; Lattarulo F; Russo M; Panno G; Milani P; Basset M; Avanzini MA; Merlini G; Palladini G; Nuvolone M
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189697
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of AL amyloidosis due to B-cell non-Hodgkin lymphoma.
Berkowitz C; Dittus C
Front Oncol; 2022; 12():915420. PubMed ID: 36591532
[TBL] [Abstract][Full Text] [Related]
18. With M-protein positive, could transthyretin amyrodosis be easily excluded? Not necessarily! Wild-type transthyretin amyrodosis with Waldenström's macroglobulinaemia: a case report.
Kinoshita H; Sugino H; Ishikawa A; Kido M; Kanegawa M; Kashiwabara A; Sumimoto Y; Masada K; Shimonaga T; Oka T
Eur Heart J Case Rep; 2022 Nov; 6(11):ytac414. PubMed ID: 36339457
[TBL] [Abstract][Full Text] [Related]
19. From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance.
Visentin A; Pravato S; Castellani F; Campagnolo M; Angotzi F; Cavarretta CA; Cellini A; Ruocco V; Salvalaggio A; Tedeschi A; Trentin L; Briani C
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326711
[TBL] [Abstract][Full Text] [Related]
20. Determinants of Drug Resistance in B-Cell Non-Hodgkin Lymphomas: The Case of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia.
Piazza F; Di Paolo V; Scapinello G; Manni S; Trentin L; Quintieri L
Front Oncol; 2021; 11():801124. PubMed ID: 35087759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
